2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Clinical Significance of Tacrolimus Trough Level at the Early Period after Kidney Transplantation

W. Park,^1,2 S. Yeo,¹ S. Kang,^1,2 H. Park,¹ K. Jin,^1,2 S. Park,^1,2 S. Han.^1,2
Clinical Trials and Electronic Health Records

J. Chen, S. Bhattachrya, M. Sirota, M. Sarwal, A. Butte.
Clinical Utility and Interpretation of CKD Stages in Living Kidney Donors

A. Massie,¹ M. Henderson,¹ F. Al Ammary,¹ J. Snyder,² D. Segev.¹
Clinical Utility of CMV-Specific CD8+ T-Cell Immune Competence Score in Lung and Heart-Lung Transplant Recipients at Risk of Cytomegalovirus Infection

A. Meesing,¹ R. Abraham,² R. Razonable.¹
Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients

B. Banas,¹ D. Steubl,² L. Renders,² D. Chittka,¹ M. Banas,¹ T. Wekerle,³ M. Koch,⁴ O. Witzke,⁵ A. Muehlfeld,⁶ C. Sommerer,⁷ A. Habicht,⁸ C. Hugo,⁹ T. Huenig,¹⁰ M. Lindemann,⁵ T. Schmidt,¹¹ A. Rascle,¹¹ S. Barabas,¹¹ L. Deml,¹¹ R. Wagner,^1,11 B. Kraemer,¹² B. Krueger.¹²
Clinically Relevant Variation of Donor-Derived Cell-Free DNA during Longitudinal Surveillance of Renal Allografts

M. Narayanan,¹ T. Alhamad,² D. Hiller,³ J. Yee,³ R. Woodward,³ J. Bromberg.⁴
Closing Pandora's Box: An Evidence Based Approach to Opioid-Tolerant Patients Following Transplantation. The Case for IV Methadone

A. Aljassem, L. Hall, S. Cohn, D. Bedi, M. Alsibae, K. Putchakayala, S. Tasleem, D. Samarapungavan, C. Carpenter, A. Koffron.
Clostridium Difficile Infection after Liver Transplant is Associated with Poor Long-Term Survival

A. Ahearn, P. Mahboub, N. Theodoropoulos, B. Movahedi, P. Martins, M. Campion, R. Nathan, A. Bozorgzadeh.
CMV and BKV Infections after Kidney Transplantation: Combined Tacrolimus/everolimus Strategy Using Antithymocyte Globulin Induction

T. Jouve,^1,4 R. Germi,^2,4 B. Janbon,¹ G. Fiard,^3,4 P. Malvezzi,¹ L. Rostaing.^1,4
CMV Mismatch Still Negatively Affects Patient and Graft Survival in the Era of CMV Prophylactic and Preemptive Therapy: A Paired Kidney Analysis

N. Leeaphorn,¹ N. Garg,² N. Thamcharoen,¹ E. Khankin,¹ F. Cardarelli,¹ M. Pavlakis.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z